Article Information
History
- May 19, 2020.
Article Versions
- Version 1 (March 20, 2020 - 07:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matt Williamsa,b,*,
- Ella Mia,b,
- Kerlann Le Calveza,b,
- Jiarong Chena,d,e,
- Lillie Pakzad-Shahabic,a,
- Seema Dadhaniaa,b,
- James Wanga,b,
- Andrew L.K.Hof and
- Simon Rabinowiczg
- aComputational Oncology Group, Imperial College London
- bRadiotherapy Department, Imperial College Healthcare Trust
- cBrain Tumour Research Centre, Imperial College London
- dClinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China
- eDepartment of Oncology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China
- fDepartment of Oncology, Addenbrooke’s Hospital, Cambridge, Cambridgeshire, UK
- gFaculty of Medicine, Imperial College London, London, UK
- ↵*Correspondance: Dr. Matt Williams, Computational Oncology Group, Radiotherapy Department, Charing Cross Hospital, London, W6 8RF Email: matthew.williams{at}imperial.ac.uk